Sort by
Refine Your Search
-
Listed
-
Country
-
Employer
- University of Oxford
- ;
- University of London
- Durham University
- KINGS COLLEGE LONDON
- University of Cambridge
- DURHAM UNIVERSITY
- Heriot Watt University
- Imperial College London
- Manchester Metropolitan University
- AALTO UNIVERSITY
- King's College London
- Nature Careers
- University of Birmingham
- University of Liverpool
- ; Royal Holloway, University of London
- ; University of Cambridge
- ; University of Copenhagen
- ; University of Southern Denmark
- Birmingham City University
- City University London
- Kingston University
- Medical Research Council
- Swansea University
- UNIVERSITY OF VIENNA
- University of Bath
- University of Newcastle
- University of Nottingham
- University of Oxford;
- 19 more »
- « less
-
Field
-
will test the ability of known and near-clinical drugs to reverse or block these changes and ultimately aims to develop a preventive breast cancer vaccine for individuals with inherited predisposition
-
will employ a multi-disciplinary approach, including protein/nucleic acid biochemistry, bacterial genetics, and phage biology to test and generate hypotheses. You will develop new ideas and approaches
-
Institute and RiverD International. The successful candidate will adapt existing and develop and test new methods for detecting metastatic lymph nodes based on their molecular signatures as captured by AF and
-
advanced patient-derived tumour models and use them to test promising therapeutic targets that exploit vulnerabilities caused by loss of the SMARCB1 gene. This role offers an excellent opportunity to further
-
). This consortium pulls together expertise from all over the University, including in diagnostics, data science, drug and vaccine design, preclinical testing and clinical testing and brings it to bear on tuberculosis
-
discoveries on the electrosolvation force. The project will use a range of optical methods to examine the interactions in colloidal and molecular systems and relate the experimental findings to theories
-
Institute for Molecular and Computational Medicine (IMCM). You will test GSK assets and targets in established models of podocyte and mesangial cell pathology relevant to glomerular diseases. You will
-
use a range of optical methods to examine the interactions in colloidal and molecular systems and relate the experimental findings to theories on the electrosolvation force under development in
-
to formulate and test hypotheses about how epigenetic factors control the life cycle of parasitic nematode, use transgenic and CRISPR methods to manipulate epigenetic regulators, and test the effects
-
testing, e.g. wear testing, corrosion testing, performance and durability testing. About the role: AMMIC is inviting ambitious and talented individuals with a background in materials science/engineering